Abstract:OBJECTIVE: We investigated the relationship between plasma miRNAs levels and inflammatory characteristics in asthmatic patients.METHODS: Eligible adults with untreated asthma (n = 35) underwent a clinical assessment, sputum induction, and assessment of pulmonary function test and Asthma Control Test (ACT) scores. Asthma phenotypes were defined using the sputum cell count. miR-199a-5p expression was measured using quantitative real-time polymerase chain reaction (qPCR). Lipopolysaccharide (LPS) stimulation was used to detect miR-199a-5p secretion from peripheral blood-derived neutrophil, lymphocyte, macrophage and BEAS-2B cells. The correlation of miR-199a-5p expression with clinical parameters was analyzed using multiple linear regression analysis. In silico analysis predicted the target genes and signaling pathway of miR-199a-5p. Transfection of miR-199a-5p mimics in human airway smooth muscle cells (HASMCs) was performed in vitro.RESULTS: The miRNA-199a-5p levels in plasma and sputum increased significantly in patients with neutrophilic asthma compared to healthy subjects (ps = 0.014 and 0.006, respectively). Expression of miR-199a-5p in the plasma of asthmatic patients positively correlated with sputum miR-199a-5p expression (r = 0.511, p = 0.021). The miR-199a-5p level was only elevated with LPS stimulation in neutrophils but not macrophages, lymphocytes, or epithelial cells from healthy controls (p < 0.01). miR-199a-5p expression increased in response to LPS (p = 0.005) and LPS combined with IL-4 (p = 0.003), but not IL-4 alone. However, peripheral neutrophils from eosinophilic asthma patients did not respond to LPS with increased miR-199a-5p expression (n = 5, p > 0.05) in contrast to the significant response from neutrophilic patients (n = 4, p < 0.0001). miR-199a-5p negatively correlated with FEV1, FVC and PEF (r = -0.377, p = 0.026; r = -0.419, p = 0.012; and r = -0.392, p = 0.024, respectively). Multivariate correlation analysis confirmed that the plasma miR-199a-5p levels negatively correlated with FEV1 in patients with asthma (Adjusted R2 = 0.164, p = 0.015). In silico analysis suggested that the WNT signaling pathway participates in miR-199a-5p mediation of smooth muscle cell hypertrophy. In vitro experiment, miR-199a-5p mimics inhibited the protein expressions of WNT2 and WNT4, decreased the c-myc expression and dramatically increased the Sm-MHC expression in HASMCs.CONCLUSION: Plasma miR-199a-5p was increased in neutrophilic asthma and negatively correlated with pulmonary function, which suggests that miR-199a-5p actively contributes to disease pathogenesis by modulating the inflammatory process and transferring the signal from inflammatory cells to structure cells.

Plasma miR-199a-5p is increased in neutrophilic phenotype asthma patients and negatively correlated with pulmonary function

MicroRNA in Children with Asthma: Findings from Bronchoalveolar Lavage Fluid

MiR-185-5p Measurement Assists in Reflecting Th1/Th2 Cell Imbalance, Inflammatory Cytokine Production, and Exacerbation Risk for Childhood Asthma.

Identification of a Plasma Mirna Biomarker Signature for Allergic Asthma: A Translational Approach

RETRACTED: MiR-185-5p measurement assists in reflecting Th1/Th2 cell imbalance, inflammatory cytokine production, and exacerbation risk for childhood asthma (Retracted article. See vol. 51, pg. 194, 2023)

Increased Mir-223-3p in Leukocytes Positively Correlated with IL-17A in Plasma of Asthmatic Patients

Airway Inflammation and Small Airway Wall Remodeling in Neutrophilic Asthma

IL-1β augments TGF-β inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics

Expression levels of plasma exosomal miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p in severe asthma patients and normal individuals with emphasis on inflammatory factors

MiRNA-192-5p Attenuates Airway Remodeling and Autophagy in Asthma by Targeting MMP-16 and ATG7.

MicroRNA-485-3p promotes the inflammatory response and extracellular matrix deposition by activating Wnt/?-catenin signaling in human airway smooth muscle cells

MiR-223 Plays a Protecting Role in Neutrophilic Asthmatic Mice Through the Inhibition of NLRP3 Inflammasome

MicroRNA-155 differentially regulates IL-13Rα1 and IL-13Rα2 expression and signaling that drives abnormal epithelial cells functions in severe asthma

Different expression levels of interleukin-36 in asthma phenotypes

Microrna-22-3p Plays A Protective Role In A Murine Asthma Model Through The Inhibition Of The Nlrp3-Caspase-1-Il-1 Beta Axis

MiR-506 Targets Polypyrimidine Tract-Binding Protein 1 to Inhibit Airway Inflammatory Response and Remodeling Via Mediating Wnt/β-catenin Signaling Pathway.

Extracellular Microrna-21 and Microrna-26A Increase in Body Fluids from Rats with Antigen Induced Pulmonary Inflammation and Children with Recurrent Wheezing

Circulating miRNAs act as potential biomarkers for asthma

Reduced MicroRNA-19a causes constitutive high expression of PRMT1 and remodeling in asthma

Circulating miRNA expression in asthmatics is age-related and associated with clinical asthma parameters, respiratory function and systemic inflammation

Exploration of plasma interleukin-27 levels in asthma patients and the correlation with lung function